NCT04130971 Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response
| NCT ID | NCT04130971 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sahlgrenska University Hospital |
| Condition | Colorectal Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2019-02-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2019-02-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams. Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.
Eligibility Criteria
Inclusion Criteria: * Colorectal cancer Exclusion Criteria: * Not colorectal cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04130971 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04130971 currently recruiting?
Yes, NCT04130971 is actively recruiting participants. Contact the research team at eva.angenete@vgregion.se for enrollment information.
Where is the NCT04130971 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT04130971 clinical trial?
NCT04130971 is sponsored by Sahlgrenska University Hospital. The trial plans to enroll 800 participants.